Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
New England Journal of MedicinePublished 10 November 1994Open access
A. John Barrett, Mary M. Horowitz, Brad H. Pollock, Mei-Jie Zhang, Mortimer M. Bortin, George R. Buchanan
Citations236
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
For children with acute lymphoblastic leukemia in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy.
Abstract
For children with acute lymphoblastic leukemia in a second remission, bone marrow transplants from HLA-identical siblings result in fewer relapses and longer leukemia-free survival than does chemotherapy.
Keywords
Medicine
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
PopulationStatistical Models Based on Counting Processes
2,914 Citations1997Xavier Bry, Per Kragh Andersen +4 more
Springer series in statisticsStatistical Models Based on Counting Processes
2,831 Citations1993Per Kragh Andersen, Ørnulf Borgan +2 more
The LancetImproved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
387 Citations1991Gaston K. Rivera, C‐H Pui +16 more
Outcome within risk groups was not significantly affected by the speed of rotation of drug pairs during continuation treatment, and various high-risk subgroups had apparently improved responses to this treatment.
BloodSix-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group
265 Citations1991G. Henze, R. Fengler +5 more
New England Journal of MedicineAllogeneic Bone Marrow Transplantation after Hyperfractionated Total-Body Irradiation and Cyclophosphamide in Children with Acute Leukemia
240 Citations1987Joel A. Brochstein, Nancy A. Kernan +6 more
It is concluded that transplantation after preparation with hyperfractionated total-body irradiation and cyclophosphamide is an effective mode of therapy in children with refractory forms of acute leukemia.
BloodMarrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival
223 Citations1989AJ Barrett, MM Horowitz +8 more
New England Journal of MedicineA Comparison of Marrow Transplantation with Chemotherapy for Children with Acute Lymphoblastic Leukemia in Second or Subsequent Remission
216 Citations1981F L Johnson, Emmanuel Thomas +4 more
It is demonstrated that marrow transplantation currently offers the best chance of long-term remission and potential cure after a child with acute lymphoblastic leukemia has had a relapse in the marrow.
Annals of Internal MedicineChemotherapy Compared with Bone Marrow Transplantation for Adults with Acute Lymphoblastic Leukemia in First Remission
163 Citations1991Mary M. Horowitz
The results suggest that bone marrow transplants currently offer no special advantage over chemotherapy for adults with acute lymphoblastic leukemia in first remission.
British Journal of HaematologyBone marrow transplantation for acute lymphoblastic leukaemia
113 Citations1982Ann Barrett, J.R. Kendra +10 more
Results show that morbidity and mortality from the bone marrow transplantation procedure is low, however, the major obstacle to permanent success in marrow tranplantation of patients with ALL is recurrence of the disease (35% actuarial disease free survival at 1126 d).
BloodHigh-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission
102 Citations1988PF Coccia, SE Strandjord +6 more
Journal of Clinical OncologyAllogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.
97 Citations1990John R. Wingard, Steven Piantadosi +8 more
BloodMarrow transplantation for children with acute lymphoblastic leukemia in second remission
93 Citations1987JE Sanders, Thomas Ed +2 more
Fifty-seven children between the ages of 3 and 17 years with acute lymphoblastic leukemia in chemotherapy-induced second bone marrow remission were given cyclophosphamide, total body irradiation, and bone marrow transplants from HLA-matched donors, and 16 died of transplant- related complications.
BloodSix-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group
92 Citations1991G. Henze, R. Fengler +5 more
Risk factor analyses showed early relapse, particularly BM relapse within 18 months, and T-cell phenotype to be independent predictors of poor outcome, and with the proposed treatment regimen long-lasting second remissions can be achieved in about one third of patients even after intensive front-line treatment.
The LancetWHICH TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA IN SECOND REMISSION?
85 Citations1987Anna Butturini, M. M. Bortin +2 more
An analysis of 871 children treated by BMT or chemotherapy showed that outcome was correlated with risk factors at diagnosis and with length of first remission, and BMT was not demonstrably superior in patients who relapsed more than 18 months after first remission.
The LancetBONE-MARROW TRANSPLANTATION IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKAEMIA IN FIRST AND SECOND REMISSION
72 Citations1987RogerH. Herzig, A. John Barrett +14 more
Whether patients with high-risk ALL should receive transplants during first remission or should initially receive chemotherapy, with transplantation being reserved for patients who relapse is determined.
The LancetBONE-MARROW TRANSPLANTATION HAS A LIMITED ROLE IN PROLONGING SECOND MARROW REMISSION IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA
67 Citations1986Judith M. Chessells, Alison Leiper +6 more
The scope of BMT as retrieval therapy for ALL is limited by the instability of second remissions; this difficulty will not be overcome by increasing the number of potential donors or the use of autologous marrow.
BloodTreatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study
67 Citations1993PD Sadowitz, SD Smith +4 more
A randomized study to compare the efficacy of doxorubicin/prednisone and cytarabine/teniposide in a multidrug retreatment chemotherapy program found prolonged second complete remissions were secured in more than one-third of children with a late BM relapse of ALL.
BloodTreatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study
63 Citations1993PD Sadowitz, SD Smith +4 more
Medical and Pediatric OncologyProlonged second remissions in childhood acute lymphocytic leukemia: A report from the childrens cancer study group
58 Citations1983Edward S. Baum, James B. Nachman +7 more
It is concluded that a modified Capizzi regimen is the most effective regimen reported to date for maintaining second and subsequent remission in childhood ALL.
BloodReinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study
58 Citations1988GR Buchanan, GK Rivera +4 more
It is concluded that the intensive reinduction program described here is a highly effective first step in the delivery of salvage therapy to patients with ALL in first marrow relapse.
BloodIndications for marrow transplantation in acute lymphoblastic leukemia
53 Citations1990NK Ramsay, JH Kersey
Treatment options and outcomes for ALL, the alternative use of matched related, or unrelated, and autologus transplantation will also be discussed, since donor options are becoming more numerous for patients with high risk ALL who undergo marrow transplantation.
CancerRecurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission
47 Citations1978Gaston K. Rivera, Sharon B. Murphy +4 more
It is concluded that, while reinduction of a second remission in ALL is comparatively easy, effective maintenance treatment for these remissions remains a difficult therapeutic problem.
Medical and Pediatric OncologyCombination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (all)
41 Citations1979Judith M. Chessells, M A Cornbleet
It is concluded that prolonged l-asparaginase therapy in combination with an anthracycline might well be used in initial or consolidation therapy for childhood ALL.
Journal of Clinical OncologyA critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia.
40 Citations1984C B Begg, PB McGlave +3 more
By defining a suitable control group, methodology for making a critical comparison between the two modalities is presented which, if applied to larger samples of patients, should help to resolve the issue.
Blood ReviewsTreatment of childhood acute lymphoblastic leukaemia: Present issues and future prospects
35 Citations1992J M Chessells
The means of identifying children for whom standard therapy is not appropriate, and the aspects of standard therapy requiring further refinement, in particular central nervous system (CNS) directed treatment and continuing (maintenance) therapy, a concept unique to ALL are reviewed.
British Journal of HaematologyPrediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantation
23 Citations1986Ann Barrett, Rajneesh Kumar Joshi +6 more
It is established that ALL is a heterogeneous disease and the importance of determining relapse risk when selecting BMT and other treatment schedules for ALL patients is established.
The Medical Journal of AustraliaPOOR OUTLOOK FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA WITH RELAPSE
23 Citations1979H. Ekert, W. Mary Ellis +2 more
A small group of children with a relapse of acute lymphoblastic leukaemia had prolonged survival and prolonged second remissions, and it is uncertain whether some of these may have a chance of “cure”.
CancerFavorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia
16 Citations1980Jim C. Kimball, Jay Herson +1 more
Twenty‐two children with acute lymphocytic leukemia who had relapsed while on therapy and for whom remissions were successfully reinduced were maintained with a combination of methotrexate, daunomycin, 6‐mercaptopurine, prednisone, and vincristine (Djerassi‐methotrexate with BOMB).
Scandinavian Journal of HaematologyCombination Chemotherapy for Marrow Relapse in Children and Adolescents with Acute Lymphocytic Leukaemia
13 Citations1981Sergio Amadori, Maria Lucia Antonietta +5 more
It is concluded that a prolonged second remission can be achieved in children with ALL in bone marrow relapse by combining intensive chemotherapy with the prevention of meningeal leukaemia.